LoginRegister
    FDA approves Cassipa as maintenance treatment for opioid dependenceFDA approves Cassipa as maintenance treatment for opioid dependence
    AstraZeneca gets FDA breakthrough therapy label for asthma treatmentAstraZeneca gets FDA breakthrough therapy label for asthma treatment
    Pfizer terminates Domagrozumab clinical studies for Duchenne muscular dystrophyPfizer terminates Domagrozumab clinical studies for Duchenne muscular dystrophy
    Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugsSupreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs
    Sun Pharma gets 6 observations by USFDA for its Halol facilitySun Pharma gets 6 observations by USFDA for its Halol facility
    Johnson and Johnson says to work on India compensation for recalled hip implantsJohnson and Johnson says to work on India compensation for recalled hip implants
    Irdai ask insurers to provide 60-days grace period for health insurance premiumIrdai ask insurers to provide 60-days grace period for health insurance premium
    GSK says USFDA wants more information on pulmonary drugGSK says USFDA wants more information on pulmonary drug
    French drugmakers urge Brexit negotiators to safeguard supply chainFrench drugmakers urge Brexit negotiators to safeguard supply chain
    Renaming drug regulator CDSCO: Health ministry invites suggestionsRenaming drug regulator CDSCO: Health ministry invites suggestions
    Aurobindo to acquire Sandoz US dermatology, oral solids business for about Rs 6,470 crore CASHAurobindo to acquire Sandoz US dermatology, oral solids business for about Rs 6,470 crore CASH
    NCLT issues notices to Malvinder, Godhvani; directs status quo over RHC HoldingsNCLT issues notices to Malvinder, Godhvani; directs status quo over RHC Holdings
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X